The FTC announced yesterday settlements with six companies accused of making a broad range of unsubstantiated health claims, including that CBD can treat cancer, heart disease, hypertension, Alzheimer’s disease, bipolar disorder, and chronic pain, among others. Nicknamed, “Operation CBDeceit,” the
Continue Reading FTC’s CBD Crackdown: Something Old and Something New
FDA and FTC Joint Warning Letters Target Amazon Affiliates Making False COVID-19 Claims
Earlier this week, federal regulators continued their efforts to combat the spread of products featuring allegedly false and misleading claims that products can diagnose, treat, cure, or prevent COVID-19. In warning letters issued to CBD Gaze, Alternavita, Musthavemom.com
Continue Reading FDA and FTC Joint Warning Letters Target Amazon Affiliates Making False COVID-19 Claims
KDW COVID-19 Resource Center Provides Critical Business Guidance
As the novel coronavirus (COVID-19) has reached pandemic levels, companies of all sizes and in all industries face myriad impacts to business operations and the health and well-being of employees.
To help clients navigate these new challenges, including the unpredictability
Continue Reading KDW COVID-19 Resource Center Provides Critical Business Guidance
Joint Warning Letter Targets CBD Claims Relating To Infant and Child Uses
Any parent who has tried in vain to soothe a child suffering from a painful ear infection or comfort a teething baby knows that feeling of desperation when you may be willing to try just about anything to get the
Continue Reading Joint Warning Letter Targets CBD Claims Relating To Infant and Child Uses
FTC Issues Warning Letters to Companies Advertising Their CBD-Infused Products as Treatments for Serious Diseases
Today, the FTC issued warning letters to three companies selling CBD products. The companies, which FTC did not identify publicly, allegedly illegally advertised CBD products as being able to treat or cure serious diseases and health conditions without competent and
Continue Reading FTC Issues Warning Letters to Companies Advertising Their CBD-Infused Products as Treatments for Serious Diseases
FDA and FTC Issue Joint Warning Letters to Three Online CBD Marketers
The FDA and FTC jointly issued warning letters to three companies selling CBD products online. The letters allege violations of the Federal Food, Drug, and Cosmetic Act (“FDCA”) and the Federal Trade Commission Act (“FTCA”). Although this is the first
Continue Reading FDA and FTC Issue Joint Warning Letters to Three Online CBD Marketers